Sysmex New Zealand has appointed a new senior management team. James Webster has stepped aside as Sysmex New Zealand CEO to focus his full attention on his role as Sysmex Australia CEO. Assuming the position of Sysmex New Zealand CEO is Arjit Bhana, formerly the company’s General Manager.

Sysmex Corporation has received the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Prize for Science and Technology (Development Category), for its Development of White Blood Cell Five-Part Differentiation and an Atypical White Blood Cell Differentiation Method.

Sysmex Corporation announces the establishment of a new company, Sysmex Harmony Co., Ltd., to promote the employment of people with disabilities.

Sysmex Corporation and the University of Tokyo have entered into a research collaboration agreement involving the development of a target gene panel. The objective is to analyze lung cancer, sarcoma and other specified types of diseases, and analyze genetic mutations related to rare diseases with a view to the clinical application of genomic medicine.

Sysmex Corporation announced today that it has signed an agreement with the National Health Laboratory (NHL), a Myanmar government institution, to conduct scientific support activities with the aim of enhancing the quality of clinical testing in the country.

Sysmex Corporation received several awards at the 2016 Kinki Local Commendations for Inventions, sponsored by the Japan Institute of Invention and Innovation. Local commendations for inventions, which are awarded to inventors who create superior technologies and designs, have a history dating back to 1921.

Sysmex Corporation has received the 14th Annual Merit Award from the Minister of Economy, Trade and Industry for Collaborative Achievement Between Industry, Academia and Government for the practical realization of a system for diagnosing hepatic fibrosis using glycosylation, developed in collaboration with the National Institute of Advanced Industrial Science and Technology, or AIST.

Sysmex Corporation announces that its subsidiary in Singapore, Sysmex Asia Pacific, has established a branch in Yangon, Myanmar.
With the new branch, the Company aims to enhance its service and after-sales support to distributors and customers in the rapidly growing market of Myanmar. At the same time, the branch will increase Sysmex’s presence in Myanmar and contribute to the development of healthcare in the country.

We are proud to announce that Sysmex stood out among more than 150 shortlisted Asian companies and has been included in the small group of 19 companies to have won the “Best Companies to Work for in Asia 2015” Award. HR Asia, one of the most well-known and Asia’s most authoritative publication for HR professionals, […]

PT Sysmex Indonesia has successfully achieved ISO 9001:2008 certification from the Certification Body; TÜV Rheinland Indonesia in relation to Trading and After-Sales Service of In-Vitro Diagnostics and Healthcare IT Products. “Customers want to be confident that they are doing business with an organization that can consistently meet or exceed their needs,” said Mr. Andry Gunawan, […]

Sysmex Philippines Inc. has successfully passed the audit for certification to ISO 9001:2008 for sales, trading, distribution, installation and servicing of healthcare IT, diagnostic and scientific instruments sales and distribution of reagents.  ISO9001:2008 sets out the criteria for a quality management system. This standard is based on a number of quality management principles including a […]

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Sydney, Australia. Through this move, Sysmex aims to enhance its sales and support networks in Australia and expand its business. Australia’s healthcare expenditure of the country has been increasing at 6% average growth from 2008 to 2012. Average growth […]